Please login to the form below

Not currently logged in
Email:
Password:

Tobi Podhaler

This page shows the latest Tobi Podhaler news and features for those working in and with pharma, biotech and healthcare.

NICE backs Novartis/ ThromboGenics’ eye drug

NICE backs Novartis/ ThromboGenics’ eye drug

ranibizumab). Novartis has also won the cost-effectiveness watchdog's backing in 2013 for the Tobi Podhaler (tobramycin), a treatment for cystic fibrosis.

Latest news

  • NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

    The limited recommendation takes into account that the Tobi Podhaler and Colobreathe are dry powder versions of already available nebulised products. ... form. The Tobi Podhaler should only be used in cystic fibrosis patients for whom nebulised

  • NICE backs two cystic fibrosis treatments for NHS use NICE backs two cystic fibrosis treatments for NHS use

    NICE backs two cystic fibrosis treatments for NHS use. Novartis’ Tobi Podhaler and Forest’ s Colobreathe recommended at discounted price. ... Novartis' Tobi Podhaler and Forest Laboratories' Colobreathe have both received backing for use in the NHS

  • NICE backs Novartis’ Tobi Podhaler in cystic fibrosis NICE backs Novartis’ Tobi Podhaler in cystic fibrosis

    NICE backs Novartis’ Tobi Podhaler in cystic fibrosis. But draft guidance doesn't recommend Forest’ s Colobreathe. ... In addition, the Tobi Podhaler should only be available for patients unable to use nebulised colistimethate, or for whom nebulised

  • FDA panel backs Novartis' updated cystic fibrosis drug FDA panel backs Novartis' updated cystic fibrosis drug

    Novartis' current tobramycin product TOBI has been the standard of care of this infection in CF since it was launched in 1997, but is delivered using a nebuliser machine which is ... The new product is already approved in the EU and Canada, where it is

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics